Bone marrow biopsy is a diagnostic procedure involving the extraction and examination of bone marrow samples to assess various conditions such as cancers and blood disorders. The market for bone marrow biopsy tools and services includes devices such as needles and diagnostic services. Bone marrow biopsy market is used in diagnosing and monitoring hematological disorders such as leukemia and lymphoma. Additionally, it aids in assessing treatment response and guiding therapeutic decisions in oncology and hematology, making it a crucial tool in healthcare.
Global Bone Marrow Biopsy Market size was valued at USD 1.10 billion in 2021 and is projected to reach USD 1.79 billion by 2029, with a CAGR of 6.3% during the forecast period of 2022-2029.
To know more, visit https://www.databridgemarketresearch.com/fr/reports/global-bone-marrow-biopsy-market
Below are the Top Bone Marrow Biopsy Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
BD
|
BD is a leading global medical technology company known for its diverse range of medical devices, including products relevant to the Bone Marrow biopsy market. The company offers biopsy needles and devices for bone marrow aspiration, catering to the needs of healthcare professionals performing bone marrow biopsies for diagnostic purposes.
|
|
U.S., Europe, Asia-Pacific
|
The BD CAREFUSION T-HANDLE JAMSHIDI TJM4008 Bone Marrow Biopsy Needle is a specialized medical instrument designed for bone marrow acquisition. It features an ergonomic design with a lightweight handle and a razor-sharp bevel tip for effective coring of the bone. The needle comes with a marrow acquisition cradle to capture and retrieve quality samples accurately. Packaged sterile for single-use, it offers multiple sampling capabilities, reducing the need for painful redirects and improving specimen retention. This product is available in a case containing 10 needles and is suitable for continental US shipping with pre-approval.
|
|
2.
|
Medtronic
|
As a prominent player in the medical technology industry, Medtronic provides innovative solutions for various medical procedures, including bone marrow biopsy. Their portfolio may include biopsy needles, aspiration systems, and other devices designed to facilitate safe and efficient bone marrow sampling, contributing to improved patient outcomes.
|
|
North America, South America, Europe, and Middle East and Africa, Asia
|
In April 2011, Medtronic company launched MARROWMAX bone marrow aspiration needle kit and expanded its leading bone grafting product portfolio. This has allowed them to serve more customers worldwide and earn more revenue collection from the segment.
|
|
3.
|
ARGON MEDICAL
|
Argon Medical, a subsidiary of BD, specializes in the development and manufacturing of medical devices for interventional procedures. Within the bone marrow biopsy market, Argon Medical may offer a range of biopsy needles and related accessories, emphasizing quality and precision to meet the needs of healthcare providers.
|
|
North America, Europe, and Middle East and Africa, Asia
|
In March 2013, ARGON MEDICAL and Roundtable healthcare partners acquired Angiotech Pharmaceutical, Inc. “interventional products business”. They market and manufacture reusable and disposable biopsy products for the diagnosis of various diseases. This acquisition has enhanced the company product portfolio for the biopsy needle category and helped in serving more customers across the globe.
|
|
4.
|
Merit Medical Systems
|
Merit Medical is recognized for its extensive portfolio of medical devices and solutions across various clinical areas. In the context of the bone marrow biopsy market, Merit Medical may provide biopsy needles, trays, and aspiration systems, offering healthcare professionals reliable tools for accurate bone marrow sampling procedures.
|
|
North America, South America, Europe, and Asia
|
Merit Medical Systems acquired inventories and intellectual property rights related to manual bone biopsy devices, manual bone marrow needles, and muscle biopsy kits from Laurane Medical S.A.S. for $16.5 million. Additionally, a contingent consideration liability of $5.5 million was recorded for potential royalties to Laurane's shareholders. This acquisition was treated as a business combination, with the purchase price allocated to the assets acquired, including those associated with bone marrow biopsy.
|
|
5.
|
Cardinal Health
|
Cardinal Health is a global healthcare services and products company that offers a range of medical devices and solutions, including those relevant to bone marrow biopsy procedures. Their offerings in the bone marrow biopsy market might encompass biopsy needles, trays, and other essential supplies, supporting healthcare providers in delivering quality patient care.
|
|
U.S.
|
Cardinal Health has launched a new single-use bone marrow biopsy needle with core retention design, aimed at enhancing ease of use and patient comfort during bone marrow procedures. This innovative needle retains the specimen within the lumen, allowing for a longer, non-fragmented biopsy sample that can be withdrawn smoothly with no rocking or gyratory motion. This development addresses the need for efficient and less painful bone marrow biopsies, reflecting advancements in the bone marrow biopsy market.
|
Conclusion
The bone marrow biopsy market plays a critical role in diagnosing and monitoring various hematological disorders, such as leukemia and lymphoma, while aiding in treatment assessment and guiding therapeutic decisions in oncology and hematology. Key players such as BD, Medtronic, ARGON MEDICAL, Merit Medical Systems, and Cardinal Health dominate the market, offering a diverse range of biopsy needles, aspiration systems, and related accessories to meet the evolving needs of healthcare professionals worldwide. As technology advances and healthcare standards continue to improve, these companies are poised to drive further advancements in bone marrow biopsy procedures, ultimately enhancing patient outcomes and quality of care.
